Skip to main navigation Skip to search Skip to main content

Development and validation of a risk score model for predicting the cardiovascular outcomes after breast cancer therapy: The chemo-radiat score

  • Do Young Kim
  • , Myung Soo Park
  • , Jong Chan Youn
  • , Sunki Lee
  • , Jae Hyuk Choi
  • , Mi Hyang Jung
  • , Lee Su Kim
  • , Sung Hea Kim
  • , Seongwoo Han
  • , Kyu Hyung Ryu
  • Hallym University
  • Konkuk University

Research output: Contribution to journal › Article › peer-review

55 Scopus citations

Abstract

BACKGROUND: Cardiovascular disease is an important cause of mortality among survivors of breast cancer (BC). We developed a prediction model for major adverse cardiovascular events after BC therapy, which is based on conventional and BC treatment-related cardiovascular risk factors. METHODS AND RESULTS: The cohort of the study consisted of 1256 Asian female patients with BC from 4 medical centers in Korea and was randomized in a 1:1 ratio into the derivation and validation cohorts. The outcome measures comprised cardiovascular mortality, myocardial infarction, congestive heart failure, and transient ischemic attack/stroke. To correct overfitting, a penalized Cox proportional hazards regression was performed with a cross-validation approach. Number of cardiovascular diseases (myocardial infarction, peripheral artery disease, heart failure, and transient ischemic attack/stroke), number of baseline cardiovascular risk factors (hypertension, age ≥60, body mass index ≥30 kg/m2, estimated glomerular filtration rate <60 mL/min per 1.73 m2, dyslipidemia, and diabetes mellitus), radiation to the left breast, and anthracycline dose per 100 mg/ m2 were included in the risk prediction model. The time-dependent C-indices at 3 and 7 years after BC diagnosis were 0.876 and 0.842, respectively, in the validation cohort. CONCLUSIONS: A prediction score model, including BC treatment-related risk factors and conventional risk factors, was developed and validated to predict major adverse cardiovascular events in patients with BC. The CHEMO-RADIAT (congestive heart failure, hypertension, elderly, myocardial infarction/peripheral artery occlusive disease, obesity, renal failure, abnormal lipid profile, diabetes mellitus, irradiation of the left breast, anthracycline dose, and transient ischemic attack/stroke) score may provide overall cardiovascular risk stratification in survivors of BC and can assist physicians in multidisciplinary decisionmaking regarding the BC treatment.

Original languageEnglish
Article numbere021931
JournalJournal of the American Heart Association
Volume10
Issue number16
DOIs
StatePublished - 17 Aug 2021

Bibliographical note

Publisher Copyright:
© 2021 The Authors.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Breast cancer
  • Major adverse cardiovascular events
  • Multicenter cohort
  • Prediction model
  • Risk stratification

Fingerprint

Dive into the research topics of 'Development and validation of a risk score model for predicting the cardiovascular outcomes after breast cancer therapy: The chemo-radiat score'. Together they form a unique fingerprint.

Cite this